Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Inflammatory Bowel Diseases

Free Subscription 05.01.2026 4 Aliment Pharmacol Ther 3 Am J Gastroenterol 1 BMC Gastroenterol 5 Clin Gastroenterol Hepatol 2 Dig Dis Sci 4 Dis Colon Rectum 1 Gastroenterol Hepatol 3 Gastroenterology 2 Gut 10 Inflamm Bowel Dis 2 J Clin Gastroenterol 8 J Crohns Colitis 1 J Immunol 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. GODDARD Q, Markovinovic A, Ronksley PE, Seow C, et al
   Meta-Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Dec 27. doi: 10.1111/apt.70492.
   PubMed         Abstract available
   
   
2. ATTAUABI M, Madsen GR, Bendtsen F, Seidelin JB, et al
   Research Communication: Sexual Dysfunction is a Common Early Challenge in Newly Diagnosed Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2026;63:288-293.
   PubMed         Abstract available
   
   
3. GIRI S, Jena A, Sharma V, Sebastian S, et al
   Editorial: The Hidden Burden-Stigmatisation in Inflammatory Bowel Disease: Authors' Reply.
   Aliment Pharmacol Ther. 2025 Dec 21. doi: 10.1111/apt.70507.
   PubMed        
   
   
4. LENTI MV, Santacroce G, Di Sabatino A
   Editorial: The Hidden Burden-Stigmatisation in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Dec 21. doi: 10.1111/apt.70478.
   PubMed        
   
   

   
   Am J Gastroenterol

5. MOUTSOGLOU D
   Continuing Medical Education Questions: January 2026.
   Am J Gastroenterol. 2026;121:29.
   PubMed         Abstract available
   
   
6. HOFFERT Y, Wang Z, Fumery M, Nachury M, et al
   A Risk Stratification Tool for Relapse After Intravenous-To-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases.
   Am J Gastroenterol. 2026;121:179-186.
   PubMed         Abstract available
   
   
7. FRIEDMAN S, Nielsen J, Andersen ML, Norgard BM, et al
   Complications of Ileus and Bowel Obstruction During Pregnancy in Women Who Have Had Surgery for Inflammatory Bowel Disease: A Population-Based Study.
   Am J Gastroenterol. 2026;121:187-194.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

8. BAO C, Xu S, Wu L, Zhu X, et al
   Integrated structural and functional brain imaging reveals biomarkers of disease activity in Crohn's disease.
   BMC Gastroenterol. 2025 Dec 30. doi: 10.1186/s12876-025-04547.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

9. OMEDE M, Itam-Eyo A, Park A, Ikobah J, et al
   Epidemiology, Natural History, and Treatment of Inflammatory Bowel Disease in Africa: A Scoping Review.
   Clin Gastroenterol Hepatol. 2026;24:41-56.
   PubMed         Abstract available
   
   
10. COELHO-PRABHU N, Ohri A, Benatzky C, Baskaran NU, et al
    Liver Transplantation Is Associated With a Reduced Risk of Colorectal Dysplasia in Patients With IBD and Concomitant PSC.
    Clin Gastroenterol Hepatol. 2026;24:181-189.
    PubMed         Abstract available
    
    
11. ANJIE SI, Gecse KB, Meloni CM, Vidal-Itriago A, et al
    Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2026;24:57-68.
    PubMed         Abstract available
    
    
12. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Week 12 Reduction in MM-SES-CD is Predictive of Delayed Response to Upadacitinib in Crohn's disease.
    Clin Gastroenterol Hepatol. 2025 Dec 26:S1542-3565(25)01067.
    PubMed         Abstract available
    
    
13. CONSTANTINE-COOKE N, Vestergaard MV, Plevris N, Monterrubio-Gomez K, et al
    Large-scale clustering of longitudinal fecal calprotectin and C-reactive protein profiles in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2025 Dec 29:S1542-3565(25)01069.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

14. PARK SJ, Park SW, Cheon JH
    Ten-Year Trend in 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients with Ulcerative Colitis: An Analysis of Korean Health Insurance Data.
    Dig Dis Sci. 2025 Dec 23. doi: 10.1007/s10620-025-09629.
    PubMed         Abstract available
    
    
15. GILMORE R, Tambakis G
    Intestinal Ultrasound for Inflammatory Bowel Disease: The Sound at the End of the Tunnel?
    Dig Dis Sci. 2025 Dec 20. doi: 10.1007/s10620-025-09623.
    PubMed        
    
    

    
    Dis Colon Rectum

16. KUWAHARA R, Uchino M, Tomoo Y, Nomura K, et al
    Right-Sided Ileostomy on Stoma Outlet Obstruction In Ulcerative Colitis: A Randomized Controlled Trial.
    Dis Colon Rectum. 2025 Dec 29. doi: 10.1097/DCR.0000000000004087.
    PubMed         Abstract available
    
    
17. HOLUBAR SD
    Expert Commentary on Flap-Assisted Perineal Closure after Proctectomy for Crohn's Disease.
    Dis Colon Rectum. 2025 Dec 26. doi: 10.1097/DCR.0000000000004102.
    PubMed        
    
    
18. REYNOLDS IS, McKenna NP
    Flap-Assisted Perineal Closure after Proctectomy for Crohn's Disease.
    Dis Colon Rectum. 2025 Dec 26. doi: 10.1097/DCR.0000000000004101.
    PubMed        
    
    
19. ELMER SE, Zuk D, Soop M, Nygren J, et al
    Ligation of Intersphincteric Fistula Tract for Perianal Fistula: Long-term Results, Functional Outcomes, and Predictors of Failure.
    Dis Colon Rectum. 2026;69:64-72.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

20. ZABANA Y, Cabez A, Casbas AG
    Etrasimod: review of the safety and practical management considerations of a new oral therapy for the treatment of ulcerative colitis.
    Gastroenterol Hepatol. 2025 Dec 20:502647. doi: 10.1016/j.gastrohep.2025.502647.
    PubMed         Abstract available
    
    

    
    Gastroenterology

21. LAMY-BESNIER Q, Theodorou I, Sokol H, De Paepe M, et al
    The Human Blood Virome Differs in Crohn's Disease.
    Gastroenterology. 2025 Dec 31:S0016-5085(25)06122.
    PubMed        
    
    
22. RUDBAEK JJ, Koziol A, Fracchia A, Ernst M, et al
    Altered Metabolites at Birth in Individuals With Later Inflammatory Bowel Disease: A Danish Cohort Study.
    Gastroenterology. 2025 Dec 31:S0016-5085(25)06212.
    PubMed        
    
    
23. PETER RIMMER, Zhang F, Scott G, Hold GL, et al
    The Gut Microbiome at the Onset of Inflammatory Bowel Disease: A Systematic Review and Unified Bioinformatic Synthesis.
    Gastroenterology. 2025 Dec 23:S0016-5085(25)06015.
    PubMed         Abstract available
    
    

    
    Gut

24. NOH Y, Choi A, Lee H, Yon DK, et al
    Proton pump inhibitors use and risk of inflammatory bowel disease in children.
    Gut. 2025 Dec 31:gutjnl-2025-337345. doi: 10.1136/gutjnl-2025-337345.
    PubMed        
    
    
25. GUDINO V, Cho JW, Caballol B, Sanzo-Machuca A, et al
    TL1A-activated T cells remodel the rectal mucosa in patients with Crohn's disease with perianal fistulising disease.
    Gut. 2025 Dec 25:gutjnl-2025-336246. doi: 10.1136/gutjnl-2025-336246.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

26. STEPHENS IJB, Murphy B, Burns L, Hannan E, et al
    CRUCIAL Insights From a Decade Long Retrospective National Audit of Total Abdominal Colectomy Outcomes for Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Dec 28:izaf314. doi: 10.1093.
    PubMed         Abstract available
    
    
27. VIOLANTE T, Ferrari D, Rottoli M, Novelli M, et al
    Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis.
    Inflamm Bowel Dis. 2025 Dec 28:izaf312. doi: 10.1093.
    PubMed         Abstract available
    
    
28. MASSIRONI S, Danese S
    Unmasking a New Trauma in Inflammatory Bowel Disease: Unequal Psychological Burden.
    Inflamm Bowel Dis. 2025 Dec 25:izaf307. doi: 10.1093.
    PubMed         Abstract available
    
    
29. GORDON ES, Goc J, Grier A, Thomas C, et al
    Altered Gut Microbiota in Pediatric Quiescent Crohn's Disease Patients with Iron Deficiency Anemia.
    Inflamm Bowel Dis. 2025 Dec 22:izaf295. doi: 10.1093.
    PubMed         Abstract available
    
    
30. ST-PIERRE J, Kellar A, George T, Miyatani Y, et al
    The Chicago Mesenteric Fat Index: A Novel Metric for Point-of-Care Intestinal Ultrasound Evaluation of Mesenteric Fat Wrapping in Crohn's Disease.
    Inflamm Bowel Dis. 2025 Dec 24:izaf268. doi: 10.1093.
    PubMed         Abstract available
    
    
31. GUO JY, Wu MC, Wang YH, Lin CC, et al
    Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data.
    Inflamm Bowel Dis. 2025 Dec 23:izaf306. doi: 10.1093.
    PubMed         Abstract available
    
    
32. LI C, Ciorba MA
    Hidden Clues in the Epithelial Brush Border: A New Prognostic Marker for Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2025 Dec 22:izaf316. doi: 10.1093.
    PubMed        
    
    
33. ZHANG P, Zhang C, Liu Z, Chen L, et al
    Risk-Stratified Biologic Efficacy in Ulcerative Colitis: A Multicenter Machine Learning Study.
    Inflamm Bowel Dis. 2025 Dec 22:izaf272. doi: 10.1093.
    PubMed         Abstract available
    
    
34. GISBERT JP, Chaparro M
    Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice.
    Inflamm Bowel Dis. 2025 Dec 22:izaf273. doi: 10.1093.
    PubMed         Abstract available
    
    
35. SALEM G, Bouvette CA, Hernandez-Rocha C, Hernandez Dominguez O, et al
    Disease Outcomes After Segmental Resection of Colonic Crohn's Disease: A Retrospective Multicenter Study.
    Inflamm Bowel Dis. 2025 Dec 22:izaf252. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Gastroenterol

36. GIRARDI P, Fons AB, Savini C, Maljaars JPW, et al
    Therapy Goals and Well-being in Older Patients With Inflammatory Bowel Disease: Therapy Goals & Wellbeing in Older Adults with IBD.
    J Clin Gastroenterol. 2025 Dec 23. doi: 10.1097/MCG.0000000000002320.
    PubMed         Abstract available
    
    
37. DUGGAL S, Khattar S, Kattamuri L, Batheja M, et al
    Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Analysis.
    J Clin Gastroenterol. 2025 Dec 31. doi: 10.1097/MCG.0000000000002323.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

38. RUEDA GARCIA JL, Lowenberg M
    Towards tailored surveillance strategies in inflammatory bowel disease: still a long way to go.
    J Crohns Colitis. 2025;19:jjaf217.
    PubMed        
    
    
39. PETITO V, Gerovska D, Piazzesi A, di Vincenzo F, et al
    Inflammatory Bowel Disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity.
    J Crohns Colitis. 2025 Dec 29:jjaf237. doi: 10.1093.
    PubMed         Abstract available
    
    
40. CHEN C, Guo Y
    Revisiting Patient Stratification and Inflammatory Assessment in Ulcerative Colitis-Associated Colorectal Cancer.
    J Crohns Colitis. 2025 Dec 27:jjaf238. doi: 10.1093.
    PubMed        
    
    
41. PRIVITERA G, Bezzio C, Buono AD, Gabbiadini R, et al
    Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study.
    J Crohns Colitis. 2025 Dec 27:jjaf239. doi: 10.1093.
    PubMed         Abstract available
    
    
42. AXI L, Wang Y, Meng W
    Research Progress on Exclusive Enteral Nutrition Combined with Biologics in the Treatment of Adult Crohn's Disease.
    J Crohns Colitis. 2025 Dec 26:jjaf236. doi: 10.1093.
    PubMed         Abstract available
    
    
43. 
    Correction to: Restoring Prostacyclin/PGI2-PTGIR signaling alleviates intestinal fibrosis in Crohn's disease via fibroblast-specific YAP/TAZ inhibition.
    J Crohns Colitis. 2025;19:jjaf142.
    PubMed        
    
    
44. DOLOVICH C, Chochinov S, Ly G, Oketola B, et al
    The complex relationship between physical activity and fatigue with socioeconomic status, and mental health factors in individuals with inflammatory bowel disease.
    J Crohns Colitis. 2025;19:jjaf212.
    PubMed         Abstract available
    
    
45. SIRANART N, Nakaphan P, Pajareya P, Laohasurayotin K, et al
    Can GLP-1 agonists be used safely in inflammatory bowel disease? A meta-analysis.
    J Crohns Colitis. 2025;19:jjaf193.
    PubMed         Abstract available
    
    

    
    J Immunol

46. HUEY LM, Rosenzweig HL, Napier RJ
    Resolving the field: a role for Nod2 in T cells.
    J Immunol. 2025;214:3188-3198.
    PubMed         Abstract available
    
    

    
    PLoS One

47. HAN PF, Cui WR, He FZ, Wu T, et al
    Analysis of common differential gene expression between rheumatoid arthritis and ulcerative colitis.
    PLoS One. 2026;21:e0339397.
    PubMed         Abstract available
    
    
48. QUEIROZ-MACHADO CRR, Hanifeh M, Bottero E, Sung CH, et al
    Abundance of bacteria and histopathologic findings in the small intestinal mucosa of dogs with chronic inflammatory enteropathies.
    PLoS One. 2025;20:e0337930.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

49. BAE M, Dong X, Avila-Pacheco J, Nguyen QD, et al
    Distinct classes of gut bacterial molybdenum-dependent enzymes produce urolithins.
    Proc Natl Acad Sci U S A. 2025;122:e2501312122.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

50. QIU Y, Zhang C, Chao K, Huang L, et al
    Development and validation of a novel clinical decision support tool for sustained remission in Crohn's disease: a multi-center real-world study.
    Scand J Gastroenterol. 2026 Jan 2:1-10. doi: 10.1080/00365521.2025.2604779.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.